triazoles has been researched along with Vaginal Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, M; Hadji, P; Hars, O; Kalder, M; Kyvernitakis, I; Ziller, V | 1 |
| Arpino, G; De Placido, G; De Placido, S; De Rosa, P; Locci, M; Nazzaro, G; Pagano, T; Schettini, F; Vallone, R | 1 |
| Barbara, G; Berlanda, N; Crosignani, PG; Fedele, L; Somigliana, E; Vercellini, P | 1 |
| Dufour, J; Green, LC; Ketas, TJ; Klasse, PJ; Moore, JP; Moroney-Rasmussen, T; Veazey, RS | 1 |
| Di Luca, M; Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Venturini, PL | 1 |
| Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I | 1 |
| Grimm, C; Hefler, LA; Nagele, F; van Trotsenburg, M | 1 |
| Abbamonte, HL; Ferrero, S; Fulcheri, E; Ragni, N; Remorgida, V | 1 |
| Brodie-Meijer, CC; Buijs, PJ; Diemont, WL | 1 |
1 review(s) available for triazoles and Vaginal Diseases
| Article | Year |
|---|---|
Medical treatment for rectovaginal endometriosis: what is the evidence?
Topics: Anastrozole; Aromatase Inhibitors; Cohort Studies; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Nitriles; Pain; Patient Preference; Randomized Controlled Trials as Topic; Rectal Diseases; Treatment Outcome; Triazoles; Vaginal Diseases | 2009 |
4 trial(s) available for triazoles and Vaginal Diseases
| Article | Year |
|---|---|
Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Anxiety; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Hot Flashes; Humans; Letrozole; Medication Adherence; Middle Aged; Musculoskeletal Pain; Nitriles; Sleep Wake Disorders; Time Factors; Triazoles; Urinary Bladder Diseases; Vaginal Diseases | 2014 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogen Receptor Modulators; Female; Humans; Image Processing, Computer-Assisted; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Norpregnenes; Prospective Studies; Rectal Diseases; Treatment Outcome; Triazoles; Triptorelin Pamoate; Ultrasonography; Vaginal Diseases; Vitamins | 2013 |
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
Topics: Anastrozole; Aromatase Inhibitors; Belgium; Body Mass Index; Breast Neoplasms; Data Interpretation, Statistical; Demography; Dyspareunia; Female; Hot Flashes; Humans; Letrozole; Logistic Models; Memory Disorders; Menopause; Middle Aged; Musculoskeletal Diseases; Nitriles; Pain; Patient Selection; Prospective Studies; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles; Urination Disorders; Vaginal Diseases; Withholding Treatment | 2004 |
Letrozole and norethisterone acetate in rectovaginal endometriosis.
Topics: Administration, Oral; Aromatase Inhibitors; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Female; Humans; Letrozole; Nitriles; Norethindrone; Norethindrone Acetate; Prospective Studies; Rectal Diseases; Triazoles; Vaginal Diseases | 2007 |
4 other study(ies) available for triazoles and Vaginal Diseases
| Article | Year |
|---|---|
Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Breast Neoplasms; Female; Humans; Lasers, Gas; Middle Aged; Nitriles; Retrospective Studies; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles; Vagina; Vaginal Diseases; Vulva | 2016 |
Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Cyclohexanes; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Macaca mulatta; Maraviroc; Receptors, CCR5; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Treatment Outcome; Triazoles; Vaginal Diseases; Virus Internalization; Virus Replication | 2010 |
Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Chi-Square Distribution; Endometriosis; Female; Humans; Nitriles; Pilot Projects; Rectal Diseases; Triazoles; Vaginal Diseases | 2005 |
Nefazodone-induced clitoral priapism.
Topics: Antidepressive Agents, Second-Generation; Clitoris; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles; Vaginal Diseases | 1999 |